Delhi High Court Stops Patanjali from Disparaging Dabur in Misleading Chyawanprash Ads

Delhi High Court Stops Patanjali from Disparaging Dabur in Misleading Chyawanprash Ads

Last Updated Jul - 03 - 2025, 03:26 PM | Source : Fela News

Delhi High Court stops Patanjali from airing misleading ads that disparage Dabur’s Chyawanprash, after Dabur accused the company of damaging its brand with exag

In a major legal development, the Delhi High Court has stopped Patanjali from airing any misleading ads that directly or indirectly disparage Dabur’s Chyawanprash. This decision came after Dabur filed a petition claiming Patanjali was running a series of advertisements that painted Dabur's product in poor light while making exaggerated claims about its own.

The issue began when Patanjali aired ads boasting that its version of Chyawanprash used more than 51 herbs, branding it superior and more authentic. In contrast, the ad described Dabur’s variant, which contains 40 herbs, as “ordinary.” Dabur argued that these comparisons weren’t just unfair they were misleading. They declared the ads created a untrue narrative in the public’s mind and harmed their long-standing reputation.

Dabur also pointed out that Patanjali’s advertisements included statements that raised safety concerns, like the presence of mercury and its impact on children, further worsening the damage. Despite earlier court warnings, Patanjali allegedly aired more than 6,000 such ads within just a week, which intensified the matter.

The court responded by issuing an interim order, stopping Patanjali from broadcasting or launching any such disparaging or misleading content until next notice. The upcoming hearing is scheduled for July 14.

At its core, this case is about fairness in business. Healthy competition is fine, but it shouldn't come at the cost of manipulating people. For Indian consumers who believe Ayurvedic products for their families’ health, clarity and honesty in advertisements matter more than anything else. The decision serves as a reminder that companies must market responsibly especially when health and trust are at stake.

Share :